경카테터 대동맥판막 치환술 시장 분석 및 예측(-2035년) : 유형별, 제품별, 기술별, 용도별, 재료 유형별, 프로세스별, 배포 방식별, 최종사용자별, 장비별

The global Transcatheter Aortic Valve Replacement Market is projected to grow from $6.8 billion in 2025 to $11.4 billion by 2035, at a compound annual growth rate (CAGR) of 5.3%. Pricing in the transcatheter aortic valve replacement market is primarily influenced by valve design, biomaterials, delivery systems, clinical performance, procedural complexity, and supporting hospital infrastructure. Advanced valves offering improved durability, positioning accuracy, hemodynamic performance, and compatibility with challenging anatomies generally command premium pricing. Overall procedure economics also include imaging, catheterization equipment, specialist expertise, hospital facilities, post-procedure monitoring, and follow-up care. Manufacturers may differentiate pricing according to valve technology, delivery configuration, and healthcare-system requirements. Hospitals and healthcare providers increasingly evaluate products based on clinical outcomes, complication reduction, procedural efficiency, and patient recovery rather than device cost alone. Regulatory requirements and specialized manufacturing processes also contribute to premium pricing.

The transcatheter aortic valve replacement (TAVR) market is primarily segmented by type, with balloon-expandable valves and self-expanding valves leading the market. Balloon-expandable valves are favored due to their precision in deployment and shorter recovery times, making them ideal for high-risk patients. Self-expanding valves, however, are gaining traction due to their flexibility and adaptability in complex anatomies. The growing elderly population and increasing prevalence of aortic stenosis are key drivers of demand in this segment.

In terms of technology, the transfemoral approach dominates the TAVR market, attributed to its minimally invasive nature and reduced procedural complications. This approach is preferred for its accessibility and shorter hospital stays, which appeal to both patients and healthcare providers. The transapical and transaortic approaches, while less common, are critical for patients with specific anatomical challenges. Technological advancements and improved procedural outcomes are propelling growth in these subsegments.

Geographical Overview

North America is expected to represent the largest regional market for transcatheter aortic valve replacement, supported by advanced cardiovascular healthcare infrastructure, high adoption of minimally invasive procedures, and strong clinical expertise in structural heart interventions. The U.S. has a large network of specialized cardiac centers and experienced interventional cardiologists capable of performing TAVR procedures. Increasing prevalence of aortic stenosis among aging populations is creating sustained demand for valve replacement. Continued improvements in transcatheter valve design, imaging, delivery systems, and procedural techniques are also expanding the eligible patient population. Strong reimbursement infrastructure and established clinical pathways further support North America's leading position.

Asia Pacific is expected to register the fastest growth in the transcatheter aortic valve replacement market, driven by aging populations, increasing cardiovascular disease burden, improving healthcare infrastructure, and growing access to minimally invasive cardiac procedures. China, Japan, South Korea, and India are expanding structural-heart programs and developing capabilities for TAVR procedures. Increasing availability of trained specialists and improvements in catheter-based technologies are helping broaden access beyond major cardiac centers. Growing healthcare expenditure and greater awareness of minimally invasive alternatives to open-heart surgery are also supporting demand. As hospitals invest in advanced cardiovascular equipment and specialist facilities, TAVR adoption is expected to expand rapidly.

Key Trends and Drivers

Shift Toward Minimally Invasive Valve Replacement Procedures:

A key trend in the transcatheter aortic valve replacement market is the shift toward minimally invasive approaches for treating aortic valve disease. TAVR enables replacement of the diseased valve through catheter-based access rather than conventional open-heart surgery. Advances in transcatheter valve design, delivery systems, imaging guidance, and procedural techniques are improving implantation precision and expanding treatment options. Continued development of smaller delivery systems and improved valve performance is supporting the use of TAVR across a broader range of patients and clinical settings.

Preference for Less Invasive Cardiovascular Interventions:

A key driver of the transcatheter aortic valve replacement market is the preference for less invasive cardiovascular interventions that can reduce surgical trauma and support faster recovery. Traditional surgical valve replacement can involve substantial procedural intervention and extended recovery, particularly among patients with elevated surgical risk. TAVR provides an alternative catheter-based approach for appropriate patients with aortic valve disease. Advances in patient selection, imaging, valve technology, and clinical experience are encouraging broader consideration of transcatheter treatment options.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by End User
• 2.6 Key Market Highlights by Deployment
• 2.7 Key Market Highlights by Material Type
• 2.8 Key Market Highlights by Process
• 2.9 Key Market Highlights by Equipment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Balloon-Expandable Valve
  • 4.1.2 Self-Expandable Valve
  • 4.1.3 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Transcatheter Heart Valves
  • 4.2.2 Delivery Systems
  • 4.2.3 Accessories
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Balloon-Expandable
  • 4.3.2 Self-Expanding
  • 4.3.3 Others
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Aortic Stenosis
  • 4.4.2 Aortic Regurgitation
  • 4.4.3 Others
• 4.5 Market Size & Forecast by End User (2020-2035)
  • 4.5.1 Hospitals
  • 4.5.2 Ambulatory Surgical Centers
  • 4.5.3 Cardiac Catheterization Labs
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Deployment (2020-2035)
  • 4.6.1 In-Hospital
  • 4.6.2 Outpatient
  • 4.6.3 Others
• 4.7 Market Size & Forecast by Material Type (2020-2035)
  • 4.7.1 Nitinol
  • 4.7.2 Cobalt-Chromium
  • 4.7.3 Stainless Steel
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Transfemoral Implantation
  • 4.8.2 Transapical Implantation
  • 4.8.3 Transaortic Implantation
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Equipment (2020-2035)
  • 4.9.1 Imaging Systems
  • 4.9.2 Catheters
  • 4.9.3 Guidewires
  • 4.9.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Application
    • 5.2.1.5 End User
    • 5.2.1.6 Deployment
    • 5.2.1.7 Material Type
    • 5.2.1.8 Process
    • 5.2.1.9 Equipment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Application
    • 5.2.2.5 End User
    • 5.2.2.6 Deployment
    • 5.2.2.7 Material Type
    • 5.2.2.8 Process
    • 5.2.2.9 Equipment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Application
    • 5.2.3.5 End User
    • 5.2.3.6 Deployment
    • 5.2.3.7 Material Type
    • 5.2.3.8 Process
    • 5.2.3.9 Equipment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Application
    • 5.3.1.5 End User
    • 5.3.1.6 Deployment
    • 5.3.1.7 Material Type
    • 5.3.1.8 Process
    • 5.3.1.9 Equipment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Application
    • 5.3.2.5 End User
    • 5.3.2.6 Deployment
    • 5.3.2.7 Material Type
    • 5.3.2.8 Process
    • 5.3.2.9 Equipment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Application
    • 5.3.3.5 End User
    • 5.3.3.6 Deployment
    • 5.3.3.7 Material Type
    • 5.3.3.8 Process
    • 5.3.3.9 Equipment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Application
    • 5.4.1.5 End User
    • 5.4.1.6 Deployment
    • 5.4.1.7 Material Type
    • 5.4.1.8 Process
    • 5.4.1.9 Equipment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Application
    • 5.4.2.5 End User
    • 5.4.2.6 Deployment
    • 5.4.2.7 Material Type
    • 5.4.2.8 Process
    • 5.4.2.9 Equipment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Application
    • 5.4.3.5 End User
    • 5.4.3.6 Deployment
    • 5.4.3.7 Material Type
    • 5.4.3.8 Process
    • 5.4.3.9 Equipment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Application
    • 5.4.4.5 End User
    • 5.4.4.6 Deployment
    • 5.4.4.7 Material Type
    • 5.4.4.8 Process
    • 5.4.4.9 Equipment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Application
    • 5.4.5.5 End User
    • 5.4.5.6 Deployment
    • 5.4.5.7 Material Type
    • 5.4.5.8 Process
    • 5.4.5.9 Equipment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Application
    • 5.4.6.5 End User
    • 5.4.6.6 Deployment
    • 5.4.6.7 Material Type
    • 5.4.6.8 Process
    • 5.4.6.9 Equipment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Application
    • 5.4.7.5 End User
    • 5.4.7.6 Deployment
    • 5.4.7.7 Material Type
    • 5.4.7.8 Process
    • 5.4.7.9 Equipment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Application
    • 5.5.1.5 End User
    • 5.5.1.6 Deployment
    • 5.5.1.7 Material Type
    • 5.5.1.8 Process
    • 5.5.1.9 Equipment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Application
    • 5.5.2.5 End User
    • 5.5.2.6 Deployment
    • 5.5.2.7 Material Type
    • 5.5.2.8 Process
    • 5.5.2.9 Equipment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Application
    • 5.5.3.5 End User
    • 5.5.3.6 Deployment
    • 5.5.3.7 Material Type
    • 5.5.3.8 Process
    • 5.5.3.9 Equipment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Application
    • 5.5.4.5 End User
    • 5.5.4.6 Deployment
    • 5.5.4.7 Material Type
    • 5.5.4.8 Process
    • 5.5.4.9 Equipment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Application
    • 5.5.5.5 End User
    • 5.5.5.6 Deployment
    • 5.5.5.7 Material Type
    • 5.5.5.8 Process
    • 5.5.5.9 Equipment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Application
    • 5.5.6.5 End User
    • 5.5.6.6 Deployment
    • 5.5.6.7 Material Type
    • 5.5.6.8 Process
    • 5.5.6.9 Equipment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Application
    • 5.6.1.5 End User
    • 5.6.1.6 Deployment
    • 5.6.1.7 Material Type
    • 5.6.1.8 Process
    • 5.6.1.9 Equipment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Application
    • 5.6.2.5 End User
    • 5.6.2.6 Deployment
    • 5.6.2.7 Material Type
    • 5.6.2.8 Process
    • 5.6.2.9 Equipment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Application
    • 5.6.3.5 End User
    • 5.6.3.6 Deployment
    • 5.6.3.7 Material Type
    • 5.6.3.8 Process
    • 5.6.3.9 Equipment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Application
    • 5.6.4.5 End User
    • 5.6.4.6 Deployment
    • 5.6.4.7 Material Type
    • 5.6.4.8 Process
    • 5.6.4.9 Equipment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Application
    • 5.6.5.5 End User
    • 5.6.5.6 Deployment
    • 5.6.5.7 Material Type
    • 5.6.5.8 Process
    • 5.6.5.9 Equipment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Edwards Lifesciences
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Medtronic
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Boston Scientific
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Abbott Laboratories
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 JenaValve Technology
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Venus Medtech
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Meril Life Sciences
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 MicroPort Scientific
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 LivaNova
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Biotronik
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Transcatheter Technologies
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Direct Flow Medical
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 NVT AG
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Heart Valve Technologies
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 CryoLife
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Sorin Group
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 St Jude Medical
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 CardiAQ Valve Technologies
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Symetis
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 AorTech International
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us